ripekg:integrity-assessment-hypothesis/RIPEAE59AF25CB9D16527-inspectai-1-1 |
rdf:type |
rdfs:Resource |
ripekg:integrity-assessment-hypothesis/RIPEAE59AF25CB9D16527-inspectai-1-1 |
rdf:type |
owl:Thing |
ripekg:integrity-assessment-hypothesis/RIPEAE59AF25CB9D16527-inspectai-1-1 |
rdf:type |
ripe:IntegrityAssessmentHypothesisIntegrity assessment hypothesis |
ripekg:integrity-assessment-hypothesis/RIPEAE59AF25CB9D16527-inspectai-1-1 |
rdf:type |
tido:Hypothesis |
ripekg:integrity-assessment-hypothesis/RIPEAE59AF25CB9D16527-inspectai-1-1 |
prov:wasAttributedTo |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI 1.0.0 |
ripekg:integrity-assessment-hypothesis/RIPEAE59AF25CB9D16527-inspectai-1-1 |
prov:wasAttributedTo |
ripekg:automated-agent/inspect-ai/1.0.0INSPECT-AI |
ripekg:integrity-assessment-hypothesis/RIPEAE59AF25CB9D16527-inspectai-1-1 |
prov:wasGeneratedBy |
ripekg:evaluation/RIPEAE59AF25CB9D16527 |
ripekg:integrity-assessment-hypothesis/RIPEAE59AF25CB9D16527-inspectai-1-1 |
prov:wasMemberOf |
ripekg:research-integrity-assessment/RIPEAE59AF25CB9D16527 |
ripekg:integrity-assessment-hypothesis/RIPEAE59AF25CB9D16527-inspectai-1-1 |
ripe:resultOutcome |
no |
ripekg:integrity-assessment-hypothesis/RIPEAE59AF25CB9D16527-inspectai-1-1 |
tido:answers |
ripekg:integrity-assessment-question/retraction-status/1.0.01.1. Does the study have an associated retraction? |
ripekg:integrity-assessment-hypothesis/RIPEAE59AF25CB9D16527-inspectai-1-1 |
tido:answers |
ripekg:integrity-assessment-question/retraction-status/1.0.0retraction status |
ripekg:publication-details/RIPEAE59AF25CB9D16527EXPRESSION OF CONCERN: The effects of melatonin administration on disease severity and sleep quality in children with atopic dermatitis: A randomized, double‐blinded, placebo‐controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAE59AF25CB9D16527-inspectai-1-1 |
ripekg:retraction-notice/67384Melatonin administration lowers biomarkers of oxidative stress and cardio-metabolic risk in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial |
tido:supports |
ripekg:integrity-assessment-hypothesis/RIPEAE59AF25CB9D16527-inspectai-1-1 |